Genomic Data Analytics: NGS Informatics Market to Hit $4.3 Billion

Overview of the NGS Informatics Market

Meticulous Research® has published a comprehensive report titled “Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030.” This detailed analysis reveals that the NGS informatics market is expected to reach a valuation of $4.3 billion by 2030, growing at a CAGR of 15.4% over the forecast period. The expansion of this market is primarily fueled by increased investments in research and development by pharmaceutical and biotechnology firms, a rising incidence of cancer and genetic disorders, and the expanding use of NGS technology in diagnostics and precision medicine. Furthermore, advancements in NGS informatics solutions and government initiatives supporting extensive genomic sequencing projects are also significant drivers. However, concerns over data confidentiality pose a challenge to this growth.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3483

As hospitals and clinical laboratories increasingly adopt NGS informatics tools, there is a surge in demand for bioinformatics and genomic data management solutions, creating opportunities for players in the market. Nonetheless, the shortage of skilled professionals proficient in NGS informatics tools remains a considerable obstacle.

Future Trends in NGS Informatics

The NGS informatics market is categorized by offering, including software (data analysis, interpretation, and reporting tools, data storage and computing tools, and Laboratory Information Management Systems [LIMS]), deployment mode (web and cloud-based, on-premise), services, application areas (disease diagnosis, biomarker discovery, drug discovery, precision medicine, agriculture and animal research), end users (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic & research institutions), and geographical distribution. The report provides a thorough evaluation of competitors and analyzes market dynamics at regional and country levels.

In 2023, the software segment is projected to dominate the NGS informatics market. The software’s capability to process, store, and share extensive volumes of genomic datasets efficiently is a significant contributing factor. This market segment benefits from the increasing need for scalable genomic data storage, emphasizing its importance.

In terms of applications, the NGS informatics market is anticipated to see the drug discovery segment leading in market share in 2023. The declining costs associated with sequencing, alongside the capacity of NGS solutions to uncover numerous mutations related to genetic conditions and to identify potential drug targets, are critical factors driving this trend.

From the perspective of end users, pharmaceutical and biotechnology companies are expected to command the largest share of the NGS informatics market in 2023. This dominance can be attributed to heightened R&D activity within these firms, an increase in sequencing information, and a trend towards outsourcing R&D projects to contract research organizations (CROs).

Geographic Analysis of the NGS Informatics Market

The research report provides an in-depth analysis of significant geographical markets, including North America (U.S. and copyright), Europe (Germany, France, U.K., Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, and the rest of Asia-Pacific), Latin America (Brazil, Mexico, and the rest of Latin America), and the Middle East & Africa.

In 2023, North America is forecasted to represent the largest share of the NGS informatics market, followed closely by Europe and Asia-Pacific. Notably, the U.S. is projected to be the dominant market within North America. This market growth is largely driven by increased R&D spending in the pharmaceutical and biotechnology sectors, the presence of leading NGS informatics companies, supportive government policies for genomic research, expanding applications of NGS technologies, and a favorable reimbursement landscape for NGS-based testing in the region.

Conclusion

The NGS informatics market is on a promising growth trajectory, bolstered by various factors such as increased R&D investments and technological advancements. While challenges remain, particularly regarding data privacy and the skills gap in the workforce, the opportunities for innovation and expansion in this market are substantial, suggesting a bright future for stakeholders involved in next-generation sequencing informatics.

Browse in Depth : https://www.meticulousresearch.com/product/ngs-informatics-market-3483

Key Players

The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).

Key questions answered in the report:

  • Which are the high-growth market segments in terms of offering, application, end user, and region/country?
  • What was the historical market size for next generation sequencing (NGS) informatics across the globe?
  • What are the market forecasts and estimates for the period 2023–2030?
  • What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market?
  • Who are the major players in the global next generation sequencing (NGS) informatics market?
  • How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market?
  • What are the recent developments in the next generation sequencing (NGS) informatics market?
  • What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market?
  • What are the geographical trends and high growth regions/countries?

Buy Now : https://www.meticulousresearch.com/Checkout/14671982

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

 

 

 

 

 

 

 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Comments on “Genomic Data Analytics: NGS Informatics Market to Hit $4.3 Billion”

Leave a Reply

Gravatar